Abeona Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 9.11 million compared to USD 22.04 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 3.8 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.48 USD | +1.82% | +12.04% | -8.98% |
May. 03 | Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise | MT |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.98% | 174M | |
+24.91% | 46.71B | |
+48.83% | 41.8B | |
-1.04% | 41.52B | |
-5.86% | 29.55B | |
+10.35% | 25.78B | |
-20.82% | 19.26B | |
+2.27% | 12.14B | |
-2.75% | 12.08B | |
+28.19% | 11.98B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Abeona Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023